Recognizing peptic ulcer disease

References

• Peterson WL, Graham DY. Helicobacter pylori. In: Feldman M, Sleisenger MH, Scharschmidt BF, eds. Sleisenger & Fordtran's gastrointestinal and liver disease: pathophysiology, diagnosis, management. 6th ed. Philadelphia: Saunders, 1998: 604–19
   Google Scholar
• Fendrick AM, Hirth RA, Chernew ME. Differences between generalist and specialist physicians regarding Helicobacter pylori and peptic ulcer disease. Am J Gastroenterol 1996; 91(8): 1544–8
   PubMed Web of Science ®Google Scholar
• Fendrick AM, Chernew ME, Hirth RA, et al. Alternative management strategies for patients with suspected peptic ulcer disease. Ann Intern Med 1995; 123(4): 260–8
   PubMed Web of Science ®Google Scholar
• Abraham P, Bhatia SJ. Position paper on Helicobacter pylori in India. Indian Society of Gastroenterology. Indian J Gastroenterol 1997; 16(Suppl 1): S29–33
   Google Scholar
• Graham DY. Nonsteroidal anti-inflammatory drugs, Helicobacter pylori, and ulcers: where we stand. Am J Gastroenterol 1996; 91(10): 2080–6
   PubMed Web of Science ®Google Scholar
• Baum C, Kennedy DL, Forbes MB. Utilization of nonsteroidal antiinflammatory drugs. Arthritis Rheum 1985; 28(6): 686–92
   PubMed Web of Science ®Google Scholar
• Gabriel SE, Bombardier C. NSAID induced ulcers: an emerging epidemic? J Rheumatol 1990; 17(1): 1–4
   PubMed Web of Science ®Google Scholar
• Fries JF. Assessing and understanding patient risk. Scand J Rheumatol 1992; 92(Suppl): 21–4
   Google Scholar
• Fries JF, Williams CA, Bloch DA, et al. Nonsteroidal antiinflammatory drug-associated gastropathy: incidence and risk factor models. Am J Med 1991; 91(3): 213–22
   PubMed Web of Science ®Google Scholar
• Fries JF. NSAID gastropathy: the second most deadly rheumatic disease? Epidemiology and risk appraisal. J Rheumatol 1991; 28(Suppl): 6–10
   Google Scholar
• Yeomans ND, Tulassay Z, Juhasz L, et al. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. N Engl J Med 1998; 338(11): 719–26
   PubMed Web of Science ®Google Scholar
• Graham DY. Prevention of gastroduodenal injury induced by chronic nonsteroidal antiinflammatory drug therapy. Gastroenterology 1989; 96(2 Pt 2 Suppl): 675–81
   PubMed Web of Science ®Google Scholar
• Agrawal NM, Roth S, Graham DY, et al. Misoprostol compared with sucralfate in the prevention of nonsteroidal antiinflammatory drug-induced gastric ulcer: a randomized, controlled trial. Ann Intern Med 1991; 115(3): 195–200
   PubMed Web of Science ®Google Scholar
• Graham DY, White RH, Moreland LW, et al. Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs: Misoprostol Study Group. Ann Intern Med 1993; 119(4): 257–62
   PubMed Web of Science ®Google Scholar
• Silverstein FE, Graham DY, Senior JR, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1995; 123(4): 241–9
   PubMed Web of Science ®Google Scholar
• Agrawal NM. Epidemiology and prevention of non-steroidal anti-inflammatory drug effects in the gastrointestinal tract. Br J Rheumatol 1995; 34(Suppl 1): 5–10
   PubMedGoogle Scholar
• Raskin JB, White RH, Jackson JE, et al. Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens. Ann Intern Med 1995; 123(5): 344–50
   PubMed Web of Science ®Google Scholar
• Hawkey CJ, Karrasch JA, Szczepanski L, et al. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs: Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group. N Engl J Med 1998; 338(11): 727–34
   PubMed Web of Science ®Google Scholar
• Kahrilas PJ. Gastroesophageal reflux disease and its complication. In: Feldman M, Sleisenger MH, Scharschmidt BF, eds. Sleisenger & Fordtran's gastrointestinal and liver disease: pathophysiology, diagnosis, management. 6th ed. Philadelphia: Saunders, 1998: 498–518
   Google Scholar
• Cutler AF. Testing for Helicobacter pylori in clinical practice. Am J Med 1996; 100(5A): 35–39S; discussion 39–41S
   Google Scholar
• Klein PD, Malaty HM, Martin RF, et al. Noninvasive detection of Helicobacter pylori infection in clinical practice: the 13C urea breath test. Am J Gastroenterol 1996; 91(4): 690–4
   PubMed Web of Science ®Google Scholar
• El-Zimaity HM, Segura AM, Genta RM, et al. Histologic assessment of Helicobacter pylori status after therapy: comparison of Giemsa, Diff-Quik, and Genta stains. Mod Pathol 1998; 11(3): 288–91
   PubMed Web of Science ®Google Scholar
• El-Zimaity HM, al-Assi MT, Genta RM, et al. Confirmation of successful therapy of Helicobacter pylori infection: number and site of biopsies or a rapid urease test. Am J Gastroenterol 1995; 90(11): 1962–4
   PubMed Web of Science ®Google Scholar
• El-Zimaity HM, Ota H, Scott S, et al. A new triple stain for Helicobacter pylori suitable for the autostainer: carbol fuchsin/Alcian blue/hematoxylin-eosin. Arch Pathol Lab Med 1998; 122(8): 732–6
   PubMed Web of Science ®Google Scholar
• Genta RM, Robason GO, Graham DY. Simultaneous visualization of Helicobacter pylori and gastric morphology: a new stain. Hum Pathol 1994; 25(3): 221–6
   PubMed Web of Science ®Google Scholar
• Yousfi MM, El-Zimaity HM, Genta RM, et al. Evaluation of a new reagent strip rapid urease test for detection of Helicobacter pylori infection. Gastrointest Endosc 1996; 44(5): 519–22
   PubMed Web of Science ®Google Scholar
• Yousfi MM, El-Zimaity HM, Cole RA, et al. Detection of Helicobacter pylori by rapid urease tests: is biopsy size a critical variable? Gastrointest Endose 1996; 43(3): 222–4
   PubMed Web of Science ®Google Scholar
• Graham DY. Can therapy even be denied for Helicobacter pylori infection? Gastroenterology 1997; 113(6 Suppl): S113–7
   Web of Science ®Google Scholar
• Greenberg PD, Koch J, Cello JP. Clinical utility and cost effectiveness of Helicobacter pylori testing for patients with duodenal and gastric ulcers. Am J Gastroenterol 1996; 91(2): 228–32
   PubMed Web of Science ®Google Scholar
• Rabeneck L, Graham DY. Helicobacter pylori: when to test, when to treat. Ann Intern Med 1997; 126(4): 315–6
   PubMed Web of Science ®Google Scholar
• Graham DY, Rabeneck L. Patients, payers, and paradigm shifts: what to do about Helicobacter pylori. Am J Gastroenterol 1996; 91(2): 188–90
   PubMed Web of Science ®Google Scholar